S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Is AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer) (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The #1 Crypto for 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Secret Bull Market Starts in This Unusual Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Is AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer) (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The #1 Crypto for 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Secret Bull Market Starts in This Unusual Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Is AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer) (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The #1 Crypto for 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Secret Bull Market Starts in This Unusual Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Is AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer) (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The #1 Crypto for 2024 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Secret Bull Market Starts in This Unusual Sector (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial

Lineage Cell Therapeutics (LCTX) Earnings Date, Estimates & Call Transcripts

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free LCTX Stock Alerts
$1.14
-0.05 (-4.18%)
(As of 04/19/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Mar. 7)
-$0.03 Beat By $0.04
Consensus EPS
(Mar. 7)
-$0.07
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

LCTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LCTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lineage Cell Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.13) EPS
Next Year EPS Consensus Estimate: ($0.12) EPS

LCTX Earnings Date and Information

Lineage Cell Therapeutics last announced its earnings data on March 7th, 2024. The reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.04. The business earned $2.09 million during the quarter, compared to analysts' expectations of $4.74 million. Lineage Cell Therapeutics has generated ($0.13) earnings per share over the last year (($0.13) diluted earnings per share). Earnings for Lineage Cell Therapeutics are expected to grow in the coming year, from ($0.13) to ($0.12) per share. Lineage Cell Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Lineage Cell Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)		------- 
3/7/2024Q4 2023($0.07)($0.03)+$0.04($0.03)$4.74 million$2.09 million
11/9/2023Q3 2023($0.04)($0.04)-($0.04)$3.30 million$1.25 million
8/10/2023Q2 2023($0.04)($0.03)+$0.01($0.03)$2.65 million$3.23 million    
5/11/2023Q1 2023($0.03)($0.03)-($0.03)$3.04 million$2.39 million
3/9/2023Q4 2022($0.03)($0.03)-($0.03)$2.97 million$1.92 million
11/10/2022Q3 2022($0.03)($0.04)($0.01)($0.04)$4.11 million$3.00 million
8/11/2022Q2 2022($0.03)($0.04)($0.01)($0.04)$4.86 million$4.55 million
5/12/2022Q1 2022$0.01($0.04)($0.05)($0.04)$12.07 million$5.24 million
3/10/2022Q4 2021($0.04)($0.05)($0.01)$0.07$1.20 million$1.20 million    
11/10/2021Q3 2021($0.05)($0.05)-($0.05)$0.56 million$2.27 million    
8/12/2021Q2 2021($0.03)($0.03)-($0.03)$1.05 million$0.51 million    
5/13/2021Q1 2021($0.04)($0.01)+$0.03($0.11)$1.07 million$0.39 million  

Lineage Cell Therapeutics Earnings - Frequently Asked Questions

When is Lineage Cell Therapeutics's earnings date?

Lineage Cell Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on LCTX's earnings history.

Did Lineage Cell Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) reported ($0.03) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.07) by $0.04. Learn more on analysts' earnings estimate vs. LCTX's actual earnings.

How much revenue does Lineage Cell Therapeutics generate each year?

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) has a recorded annual revenue of $8.94 million.

How much profit does Lineage Cell Therapeutics generate each year?

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) has a recorded net income of -$21.49 million. LCTX has generated -$0.13 earnings per share over the last four quarters.

What is Lineage Cell Therapeutics's EPS forecast for next year?

Lineage Cell Therapeutics's earnings are expected to grow from ($0.13) per share to ($0.12) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSEAMERICAN:LCTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Urgent alert: open this for a huge profit potential
Timothy Sykes